Effects of sacubitril valsartan on clinical and echocardiographic parameters of outpatients with heart failure and reduced ejection fraction

AIM: Sacubitril valsartan (SV) has revolutionized disease history in patients with heart failure and reduced ejection fraction (HFrEF). Our study assessed SV impact on clinical and echocardiographic parameters in HFrEF outpatients previously treated with optimized therapy. METHODS: Forty-nine HFrEF...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Int J Cardiol Heart Vasc
Asıl Yazarlar: Landolfo, Matteo, Piani, Federica, Esposti, Daniela Degli, Cosentino, Eugenio, Bacchelli, Stefano, Dormi, Ada, Borghi, Claudio
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Elsevier 2020
Konular:
Original Paper
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7586107/
https://ncbi.nlm.nih.gov/pubmed/33134479
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijcha.2020.100656
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller